Literature DB >> 20417673

Temperature-induced gel formation of core/shell nanoparticles for the regeneration of ischemic heart.

Keun Sang Oh1, Ji Young Song, So Jeong Yoon, Yongdoo Park, Dongmin Kim, Soon Hong Yuk.   

Abstract

Vascular endothelial growth factor (VEGF)-loaded core/shell nanoparticles were prepared and their gelation behavior in response to temperature was characterized for the regeneration of ischemic heart. The core is composed of lecithin containing VEGF and the shell is composed of Pluronic F-127 (poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer). When Capryol 90 (propylene glycol monocaprylate) was added to an aqueous solution of the core/shell nanoparticles, a temperature-induced gel composed of core/shell nanoparticles was observed to form at body temperature. This phenomenon was utilized for the stable localization of core/shell nanoparticles at the ischemic area. For an in vivo assessment, VEGF-loaded core/shell nanoparticles with and without inducement of the gel formation were applied to a subacute myocardial infarction model in rats and functional analysis of the heart was monitored by means of a PV catheter four weeks later. The results showed that the VEGF-loaded core/shell nanoparticles and their gel improved the heart functions, particularly with regard to the ejection fraction and cardiac output. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417673     DOI: 10.1016/j.jconrel.2010.04.014

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

Review 1.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 2.  Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.

Authors:  Hassan K Awada; Mintai P Hwang; Yadong Wang
Journal:  Biomaterials       Date:  2015-12-29       Impact factor: 12.479

3.  Nanocomposite hydrogels: an emerging biomimetic platform for myocardial therapy and tissue engineering.

Authors:  Arghya Paul
Journal:  Nanomedicine (Lond)       Date:  2015-05       Impact factor: 5.307

4.  Nanoparticles administered intrapericardially enhance payload myocardial distribution and retention.

Authors:  Victor Segura-Ibarra; Francisca E Cara; Suhong Wu; David A Iruegas-Nunez; Sufen Wang; Mauro Ferrari; Arturas Ziemys; Miguel Valderrabano; Elvin Blanco
Journal:  J Control Release       Date:  2017-07-09       Impact factor: 9.776

Review 5.  Direct-write bioprinting three-dimensional biohybrid systems for future regenerative therapies.

Authors:  Carlos C Chang; Eugene D Boland; Stuart K Williams; James B Hoying
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2011-04-18       Impact factor: 3.368

Review 6.  Polymeric nanoparticles in the diagnosis and treatment of myocardial infarction: Challenges and future prospects.

Authors:  Mia Karam; Duaa Fahs; Batoul Maatouk; Brouna Safi; Ayad A Jaffa; Rami Mhanna
Journal:  Mater Today Bio       Date:  2022-04-04

7.  Engineered andrographolide nanoparticles mitigate paracetamol hepatotoxicity in mice.

Authors:  Partha Roy; Suvadra Das; Runa Ghosh Auddy; Achintya Saha; Arup Mukherjee
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

Review 8.  Current Trends in Biomaterial Utilization for Cardiopulmonary System Regeneration.

Authors:  Adegbenro Omotuyi John Fakoya; David Adeiza Otohinoyi; Joshua Yusuf
Journal:  Stem Cells Int       Date:  2018-04-29       Impact factor: 5.443

Review 9.  Nanomaterials for treating cardiovascular diseases: A review.

Authors:  Wensen Jiang; Dana Rutherford; Tiffany Vuong; Huinan Liu
Journal:  Bioact Mater       Date:  2017-12-06

Review 10.  Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches.

Authors:  Julian Bejarano; Mario Navarro-Marquez; Francisco Morales-Zavala; Javier O Morales; Ivonne Garcia-Carvajal; Eyleen Araya-Fuentes; Yvo Flores; Hugo E Verdejo; Pablo F Castro; Sergio Lavandero; Marcelo J Kogan
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.